Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Graefen

Showing results (61-70 of 113) with videos related to

Pageof 12
Sort By:
Anticancer Research|May 1, 2001
Analysis of molecular isoforms of PSA and their ratios in men with PSA-relapse after radical prostatectomyP Hammerer, M Graefen, R P Henke, et al.
Cancer|September 10, 1998
Interphase cytogenetic study of preoperative core biopsies for the prediction of early serum prostate specific antigen recurrence after radical prostatectomy of clinically localized prostate carcinomaR P Henke, P Hammerer, M Graefen, et al.
Der Urologe. Ausg. A|August 15, 2009
[PSA--Quo vadis?]C Börgermann, H Loertzer, H-J Luboldt, et al.
Aktuelle Urologie|January 28, 2006
[Success rates of two-layer, microsurgical vasovasostomy. Results from a patient questionnaire and comparison with one-layer technique]M G Friedrich, E Friedrich, M Graefen, et al.
Der Urologe. Ausg. A|August 31, 2006
[PSA 2010--the beginning of a new era in early detection of prostate cancer]C Börgermann, M Sieverding, P Fornara, et al.
World Journal of Urology|November 26, 2013
Comparison of prostate cancer volume measured by HistoScanning™ and final histopathological resultsJ Schiffmann, J Fischer, P Tennstedt, et al.
Urology|March 24, 1998
Incidence of positive surgical margins after biopsy-selected nerve-sparing radical prostatectomyM Graefen, P Hammerer, U Michl, et al.
Der Urologe. Ausg. A|March 27, 2004
[Influence of transrectal endosonography on the clinical staging of impalpable prostate cancer. A controversy over the TNM system]P G Hammerer, H Augustin, J Blonski, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
A validated strategy to select patients for a nerve-sparing radical prostatectomyM Graefen, U Pichlmeier, P G Hammerer, et al.
The Prostate|October 3, 2001
Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/mlA Haese, M Graefen, T Steuber, et al.
Pageof 12

Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
Anticancer Research|May 1, 2001
Analysis of molecular isoforms of PSA and their ratios in men with PSA-relapse after radical prostatectomyP Hammerer, M Graefen, R P Henke, et al.
Cancer|September 10, 1998
Interphase cytogenetic study of preoperative core biopsies for the prediction of early serum prostate specific antigen recurrence after radical prostatectomy of clinically localized prostate carcinomaR P Henke, P Hammerer, M Graefen, et al.
Der Urologe. Ausg. A|August 15, 2009
[PSA--Quo vadis?]C Börgermann, H Loertzer, H-J Luboldt, et al.
Aktuelle Urologie|January 28, 2006
[Success rates of two-layer, microsurgical vasovasostomy. Results from a patient questionnaire and comparison with one-layer technique]M G Friedrich, E Friedrich, M Graefen, et al.
Der Urologe. Ausg. A|August 31, 2006
[PSA 2010--the beginning of a new era in early detection of prostate cancer]C Börgermann, M Sieverding, P Fornara, et al.
World Journal of Urology|November 26, 2013
Comparison of prostate cancer volume measured by HistoScanning™ and final histopathological resultsJ Schiffmann, J Fischer, P Tennstedt, et al.
Urology|March 24, 1998
Incidence of positive surgical margins after biopsy-selected nerve-sparing radical prostatectomyM Graefen, P Hammerer, U Michl, et al.
Der Urologe. Ausg. A|March 27, 2004
[Influence of transrectal endosonography on the clinical staging of impalpable prostate cancer. A controversy over the TNM system]P G Hammerer, H Augustin, J Blonski, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
A validated strategy to select patients for a nerve-sparing radical prostatectomyM Graefen, U Pichlmeier, P G Hammerer, et al.
The Prostate|October 3, 2001
Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/mlA Haese, M Graefen, T Steuber, et al.
Pageof 12